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ABSTRACT 
Emblica  officinalis  (Amla)  is  traditionally  used  for  several  diseases,  and  it  is  believed  to  increase  the  defense  against  diseases.  It  is 
particularly used for the treatment of cancer, diabetes, liver disorders, heart disease, ulcer, snake venom, haemorrhage, diarrhea, dysentery, 
anaemia and ophthalmic disorders. The antioxidant, immunomodulatory, anticancer, cytoprotective, analgesic, antimicrobial, antipyretic, 
antitussive and gastroprotective are the important properties of amla. Vitamin C, tannins and flavaniods present in amla have very powerful 
antioxidant activities. Due to rich vitamin C, amla is successfully used in the treatment of human scurvy.  
KEYWORDS: Emblica officinalis (Amla), activities as antioxidant, immunomodulatory and anticancer.   
 
INTRODUCTION 
Emblica officinalis Gaertn. (Phyllanthus emblica Linn., 
Amla,  Indian  Gooseberry)  belongs  to    Euphorbiaceae 
family.  Amla  fruits  are  acrid,  cooling,  refrigerant, 
astringent,  diuretic  and  laxative.  The  raw  fruits  are 
aperient;  while  the  dried  fruits  are  useful  in 
inflammation,  haemorrhage,  cough,  diarrhoea  and 
dysentery,  and  in  combination  with  iron,  used  for 
anaemia,  jaundice  and  dyspepsia.  The  flowers  of  E. 
officinalis are cooling, refrigerant and aperient; while the 
root  and  bark  are  astringent.  The  fermented  liquor 
prepared from the fruits is used in jaundice, dyspepsia 
and cough. Exudation from incision on the fruit is used 
as external application for the inflammation of eye. E. 
officinalis  seeds  are  used  for  asthma,  bronchitis  and 
biliousness.  E.  officinalis  fruit  contains  ellagic  acid, 
gallic  acid,  quercetin,  kaempferol,  emblicanin, 
flavonoids, glycosides and proanthocyanidins. Vitamin C 
(ascorbic acid or ascorbate), tannins (e.g., emblicanins A 
and  B)  and  flavonoids  present  in  amla  have  very 
powerful immunomodulatory, antioxidant and anticancer 
activities.  Due  to  rich  vitamin  C,  amla  is  successfully 
used in the treatment of human scurvy. Quercetin present 
in amla has hepatoprotective effect. Fruit has also been 
reported to contain phyllemblic acid, gallic  acid, lipid, 
emblicol, colloidal complexes, micic acid, amino acids 
and minerals. Phyllembin, from fruit pulp identified as 
ethyl  gallate;  tannin  from  bark  and  leaves;  fixed  oil, 
essential  oil  and  phophatides  from  seeds;  and 
leucodelphinidin  from  bark  of  E.  officinalis  have  also 
been isolated. Phyllembin potentiates the pharmacologic 
action of adrenaline in vitro and in vivo
1-3.  
E.  officinalis  is  also  used  as  antipyretic,  analgesic, 
cytoprotective,  antitussive  and  gastroprotective. 
Additionally,  it  is  useful  in  memory  enhancing, 
ophthalmic disorders and lowering cholesterol level. It is 
also helpful in neutralizing snake venom and used as an 
antimicrobial  agent.  A  number  of  medicinal  plants, 
traditionally used for thousands of years, are present in a 
group  of  herbal  preparations  of  the  Indian  traditional 
health  care  system  (Ayurveda)  named  “Rasayana”, 
identified  for  their  interesting  antioxidant  activities, 
indicating that E. officinalis also has antioxidant activity. 
E.  officinalis  is  often  incorporated  in  the  herbal 
formulation  called  “Triphla”, which contains the equal 
proportions  of  the  fruits  of  E.  officinalis,  Terminalia 
chebula  and  Terminalia  belerica.  Triphla,  due  to  its 
strong  antioxidant  activity,  restores  the  noise-stress 
induced  changes.  Albino  rats  were  used  to  assess  the 
immunomodulatory  activities  of  Triphla  on  various 
neutrophil  functions  like  adherence,  phagocytic  index, 
avidity  index  and  nitro  blue  tetrazolium.  Oral 
administration  of  Triphla  appeared  to  stimulate  the 
neutrophil  functions  in  the  immunized  rats,  and  stress Pandey Govind et al. IRJP 2 (8) 2011 38-42 
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induced  suppression  in  the  neutrophil  functions  was 
significantly prevented by Triphla. This formulation has 
been reported to exhibit the chemopreventive potential. 
The presence of Triphla in diet had significantly lowered 
the  benzo(a)pyrene  induced  forestomach 
papillomagenesis  in  mice.  Triphla  also  significantly 
increased the antioxidant status of animals which might 
have contributed to the chemoprevention. The cytotoxic 
effects of aqueous extract of Triphla were investigated 
on a transplantable mouse thymic lymphoma (barcl-95) 
and  human  breast  cancer  cell  line  (MCF-7).  The 
differential response of normal cells and tumour cells to 
Triphala  in  vitro  and  the  substantial  regression  of 
transplanted tumour in mice fed with Triphla indicate its 
potential use as an anticancer drug for clinical treatment
4. 
Suppression of the growth of cancer cells due to gallic 
acid-  a  major  polyphenol  as  observed  in  Triphala  has 
also  been  reported
5.  “EuMil”  is  another  polyherbal 
formulation composed of the standardized extracts of O. 
sanctum,  W.  somnifera,  Asparagus  racemosus  and  E. 
officinalis. This drug  is used as an anti-stress agent to 
attenuate the various aspects of stress related disorders. It 
shows  the  significant  anti-stress  and  adaptogenic 
activities against a number of behavioural, biochemical 
and  physiological  perturbations,  induced  by 
unpredictable  stress,  which  has  been  proposed to  be  a 
better indicator of clinical stress than acute stress. The 
contribution of the  individual constituents of EuMil  in 
the adaptogenic action has also been reported
4. Another 
herbal  formulation,  “ProImmu” which also contains E. 
officinalis including Ocimum sanctum (Tulsi), Tinospora 
cordifolia  (Giloe)  and  Withania  somnifera,  has  been 
reported as anticancer and immunomodulatory drug. The 
immunomodulatory  activity  of  Immu-21  (a  research 
name of ProImmu) containing the extract of was studied 
on proliferative response of splenic leukocytes to T cell 
mitogens, concanavalin-A and phytohemagglutinin, and 
B  cell  mitogen,  lipopolysaccharide  (LPS)  in  vitro  by 
[3H]-thymidine uptake assay in mice. Pretreatment with 
Immu-21 selectively elevated the proliferation of splenic 
leukocyte to B cell mitogen, LPS and cytotoxic activity 
against K 562 cells in mice
6-7.  
In view of the above facts, the present article has been 
put forth to discuss the antioxidant, immunomodulatory 
and anticancer activities of E. officinalis as reported by 
various authors.   
ANTIOXIDANT ACTIVITY OF E. OFFICINALIS     
It is increasingly being realized now that majorities of 
the  diseases  are  mainly  due  to the  imbalance  between 
pro-oxidant and anti-oxidant homeostatic phenomenon in 
the body. Pro-oxidant condition dominates either due to 
increased  generation  of  free  radicals  and/or  their  poor 
quenching/scavenging  into  the  body.  Free  radicals  are 
the  fundamental  to  any  biochemical  process,  and 
represent  an  essential  part  of  the  aerobic  life  and  our 
metabolism.  They  are  continuously  produced  by  body, 
such  as  respiration  and  some  cell  mediated  immune 
functions.  There  is  a  dynamic  balance  between  the 
amount of free radicals generated in the body and anti-
oxidant to quench and or/scavenge them and protect the 
body  against  the  deleterious  effects.  Thus,  the  oxidant 
status in human reflects the dynamic balance between the 
antioxidant defense and pro-oxidant conditions and has 
been suggested as a useful tool in estimating the risk of 
oxidative damage
4. 
Ethyl acetate extract of amla has been reported to reduce 
the elevated levels of urea nitrogen and serum creatinine 
in  aged  rats.  Oral  administration  of  this  extract 
significantly  reduced  the  thiobarbituric  acid-reactive 
substance  levels  of  serum,  renal  homogenate  and 
mitochondria  in aged rats, suggesting that amla would 
ameliorate  the  oxidative  stress  under  aging.  Increased 
inducible  nitric  oxide  synthase  and  cyclooxygenase 
(COX)-2 expression in the aorta of aging rats were also 
significantly suppressed by ethyl acetate extract of amla. 
This  extract  reduced  the  COX-2  and  nitric  oxide 
synthase  expression  levels  by  inhibiting  NF-kappaB 
activation in the aged rats. Thus, amla would be a very 
useful antioxidant for the prevention of age-related renal 
disease
8.  Pre-feeding  of  amla  appeared  to  reduce  the 
hexachlorocyclohexane  (HCH)-induced  raise  in  renal 
gamma-glutamyl  transpeptidase  (GGT)  activity.  This 
shows  the  elevation  of  hepatic  antioxidant  system  and 
lowering of cytotoxic products as which were otherwise 
affected  by  the  administration  of  HCH
9.  Rats  were 
examined for the antioxidant properties of amla extracts 
and its effect on the oxidative stress in streptozotocin-
induced diabetes was also reported. The extracts showed 
strong  free  radical  scavenging  activity.  Amla  extracts 
orally administered to the diabetic rats slightly improved 
body weight gain and also significantly increased various 
oxidative stress indices of the serum of the diabetic rats. 
Moreover the decreased levels of albumin in the diabetic 
rats were significantly improved with this drug. It also 
significantly  improved  the  serum  adiponectin  levels. 
Thus, amla can be used for relieving the oxidative stress 
and  improving  glucose  metabolism  in  diabetes
10.  E. 
officinalis is used to protect the skin from the devastating 
effects of free radicals, non-radicals and transition metal-
induced  oxidative  stress.  It  is  suitable  for  use  in  anti-
aging,  general  purpose  skin  care  products  and  as 
sunscreen
11.  E.  officinalis  fruits  contain  tannoid 
principles that have been reported to exhibit antioxidant 
activity in vitro and in vivo. Emblicanin-A (37%) and -B Pandey Govind et al. IRJP 2 (8) 2011 38-42 
IRJP 2 (8) August 2011    Page 38-42 
(33%) enriched fractions of fresh juice of E. officinalis 
fruits were  investigated  for antioxidant activity  against 
ischemia-reperfusion-induced  oxidative  stress  in  rat 
heart. The study confirmed the antioxidant effect of E. 
officinalis and also indicated that the fruits of plant may 
exhibit  a  cardioprotective  effect
12.  The  antioxidant 
activity  of  E.  officinalis  extract  associated  with  the 
presence of hydrolyzable tannins having ascorbic acid-
like  action  have  been  also  reported
13.  E.  officinalis 
contains tannoid principles comprising of emblicanin A, 
emblicanin  B,  punigluconin  and  pedunculagin,  which 
have been reported to posses antioxidant activity in vitro 
and  in  vivo
14.  Ellagic  acid,  as  a  powerful  antioxidant 
present  in  E.  officinalis,  has  the  ability  to  inhibit 
mutations  in  genes  and  repairs  the  chromosomal 
abnormalities
1.  
IMMUNOMODULATORY  ACTIVITY  OF  E. 
OFFICINALIS     
Immune activation is an effective as well as protective 
approach  against  emerging  infectious  diseases.  E. 
officinalis  has  been  reported  to  inhibit  chromium-
induced  free  radical  production,  and  it  restored  the 
antioxidant status back to control level. It also inhibited 
the  apoptosis  and  DNA  fragmentation  induced  by 
chromium. It relieved the immunosuppressive effect of 
chromium  on  lymphocyte  proliferation,  and  even 
restored  the  IL-2  and  gamma-IFN  production
15.  E. 
officinalis and Evolvulus alsinoides (Shankhpushpi) were 
assessed  for  immunomodulatory  activity  in  adjuvant 
induced  arthritic  (AIA)  rat  model.  Complete  Freund’s 
Adjuvant (CFA) was injected in right hind paw of the 
animals induced inflammation. Lymphocyte proliferation 
activity  and  histopathological  severity  of  synovial 
hyperplasia  were  used  to  study  the  antiinflammatory 
response of both the extracts, which showed a marked 
reduction  in  inflammation  and  oedema,  and  caused 
immunosuppression  in  AIA  rats,  indicating  that  these 
drugs  may  provide  an  alternative  approach  for  the 
treatment of arthritis
16. The immunomodulatory activity 
of the combined extracts of O. sanctum, W. somnifera 
and E. officinalis was noticed
17.  
ANTICANCER ACTIVITY OF E. OFFICINALIS     
E. officinalis inhibits the growth and spread of various 
cancers, including breast, uterus, pancreas, stomach and 
liver cancers, and malignant ascites. It reduces the side 
effects of chemotherapy and radiotherapy
1. E. officinalis 
reduced  the  cytotoxic  effects  in  mice  dosed  with 
carcinogens
18. E. officinalis has been reported to possess 
many medicinal properties, including immune-stimulator
 
and  antitumour  activities
19.  Amla  fruit  contains  18 
compounds that inhibit the growth of tumour cells such 
as gastric and uterine cancer cells
20. It enhances natural 
killer (NK) cell activity in various tumours. Its extract 
reduced  the  ascites  and  solid  tumours  induced  by 
Dalton’s lymphona ascites cells in mice. The extract also 
increased  the  life  span  of  tumour  bearing  animals
1,6. 
Emblicanins A and B (tannins) present in E. officinalis, 
have  been  reported  to  possess  strong  antioxidant  and 
anticancer properties
1. 
Chemoprevention with food phytochemicals is presently 
considered  as  one  of  the  most  important  strategies  to 
control  cancer.  Chemopreventive  potential  of  amla 
extract  on  7,12-dimethylbenz(a)anthracene  (DMBA) 
induced skin tumorigenesis  in  Swiss albino  mice  have 
been  found
21. E. officinalis fruit administered orally at 
different  concentrations  (100,  250,  500  mg/kg)  for  7 
consecutive days in Swiss albino mice prior to a single 
intraperitoneal  injection  of  DMBA,  decreased  the 
frequency of bone marrow micronuclei. The protection 
provided  by  E.  officinalis  fruit  may  be  due  to  its 
antioxidant capacity and through its immunomodulatory 
effect on hepatic activation and detoxifying enzymes
22. 
Phenolic compounds derived from amla exhibit a number 
of beneficial effects and can potentially  inhibit  several 
stages  of  carcinogenesis.  Efficacy  of  the  polyphenol 
fraction of E. officinalis on the induction of apoptosis in 
mouse  and  human  carcinoma  cell  lines,  and  its 
immunomodulatory  effect  on  N-nitrosodiethylamine 
(NDEA)  induced  liver  tumours  in  rats  was  also 
investigated.  The  polyphenol  fraction  of  E.  officinalis 
could induce the apoptosis in Dalton’s lymphoma ascites 
(DLA) and CeHa cell lines. The polyphenol fraction also 
inhibited  the  DNA  topoisomerase  I  in  Saccharomyces 
cervisiae, mutant cell cultures and the activity of cdc25 
tyrosine  phosphatase
23.  Amla  extract  was  found  most 
active  in  inhibiting  in  vitro  cell  proliferation  towards 
human  tumour  cell  lines,  including  human 
erythromyeloid  K562,  T-lymphoid  Jurkat,  B-lymphoid 
Raji, erythroleukemic HEL cell lines
24.  
Cyclophosphamide is one of the most famous alkylating 
anticancer  drugs  in  spite  of  its  toxic  side  effects, 
including  hematotoxicity,  immunotoxicity  and 
mutagenicity. E. officinalis  may  be the  beneficial as a 
component  of  combination  therapy  in  cancer  patients 
under  cyclophosphamide  treatment
25.  Phenolic 
compounds  and  the  major  components  from  the  fruit 
juice of E. officinalis and from the branches, leaves and 
roots  showed  stronger  inhibition  against  B16F10  cell 
growth  than  against  HeLa  and  MK-1  cell  growth. 
Norsesquiterpenoid  glycosides  from  the  roots  showed 
significant  antiproliferative  activities
20.  The 
cytoprotective  and  immunomodulating  properties  of  E. 
officinalis  against  chromium  (VI)  induced  oxidative 
damage  have  been reported
26. These  workers observed Pandey Govind et al. IRJP 2 (8) 2011 38-42 
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that the chromium (VI) at 1 µg/ml was highly cytotoxic; 
it enhanced the free radical production and decreased the 
reduced  glutathione  (GSH)  levels  and  glutathione 
peroxidase (GPx) activity in macrophages. However, the 
presence of amla resulted in an enhanced cell survival, 
decreased free radical production and higher antioxidant 
levels similar to that of control cells. Further, chromium 
(VI)  treatment  resulted  in  decreased  phagocytosis  and 
gamma-interferon  production,  while  amla  inhibited  the 
chromium induced immunosuppression and restored both 
phagocytosis  and  gamma-interferon  production  by 
macrophages significantly.  
CONCLUSION 
E.  officinalis  fruit  (Amla)  has  been  said  to  be  useful 
against many severe diseases, including cancer, diabetes, 
hepatic disorders and heart diseases. Different biological 
activities  of  amla  include  antioxidant, 
immunomodulatory,  anticancer,  cytoprotective, 
analgesic,  antimicrobial,  antipyretic,  antitussive  and 
hepatoprotective,  etc.  The  present  article  emphasizes 
particularly on the antioxidant, immunomodulatory and 
anticancer  activities  of  amla.  It  is  now  realized  that 
majorities  of  the  diseases  are  chiefly  due  to  the 
imbalance  between  pro-oxidant  and  anti-oxidant 
homeostatic  phenomenon  in  the  body,  and  the  amla 
balances  this  because  of  its  antioxidant  activity.  Amla 
also has immunostimulatory as well as protective effects 
against many emerging infectious diseases. E. officinalis 
inhibits  the  growth  and  spread  of  many  cancers, 
including  breast,  uterus,  pancreas,  stomach  and  liver 
cancers. It also reduces the side effects of chemotherapy 
and radiotherapy. Therefore, the detailed research must 
be done on amla so as to get a new natural anticancer 
drug  which  will  be  a  miracle  in  the  field  of 
pharmaceutical sciences.   
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